MedPath
HSA Approval

JUBREXA ORODISPERSIBLE TABLET 10MG

SIN15496P

JUBREXA ORODISPERSIBLE TABLET 10MG

JUBREXA ORODISPERSIBLE TABLET 10MG

May 28, 2018

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, ORALLY DISINTEGRATING

ORAL

Medical Information

N05AH03

olanzapine

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

JUBILANT GENERICS LIMITED

Active Ingredients

Olanzapine

10mg

Olanzapine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

JUBREXA ORODISPERSIBLE TABLET 10MG - HSA Approval | MedPath